Abstract
Based on previous findings of this laboratory that a single exposure to a stressful stimulus can induce a very long-lasting, sensitizing influence on the actions of drugs of multiple clinical and structural classes, the hypothesis was tested that a single stressful event might exert such an action on the alpha-2 norepinephrine agonist clonidine. Male rats received a single injection of the highly stressful convulsant stimulant pentylenetetrazole (PTZ; 40 mg/kg, IP) and were tested for locomotion after treatment with clonidine (25μg/kg, IP) 1 h, 1 week or 2 weeks later. As expected, clonidine itself induced the hypokinesia typically associated with low doses of this compound. More importantly, all groups pretreated with PTZ showed a significant enhancement of this effect. The influence of PTZ 1 or 2 weeks prior to clonidine cannot be explained as simply due to a lingering impairment of locomotion by PTZ, since no hypokinesia was observed when activity in these groups was examined immediately prior to clonidine administration. Such impairment appears, however, to have been a factor in the heightened hypokinesia observed in the group receiving PTZ only 1 h before clonidine. Mass spectrometric analysis of norepinephrine, and 3-methoxy-4-hydroxyphenylglycol levels in hippocampus and cortical areas failed to reveal any changes which could explain the persistent behavioral sensitization we observed. Plasma corticosterone determinations confirmed the stressful nature of PTZ but similarly failed to provide an explanation for the observed behavioral sensitization. The major finding of a long-term sensitizing influence on clonidine of an acute stressful experience is consistent with what is known of the precipitants and treatment of panic disorden.
Similar content being viewed by others
References
Antelman SM (1988) Time-dependent sensitization as the cornerstone for a new approach to pharmacotherapy: drugs as foreign/stressful stimuli. Drug Dev Res 14:1–30
Antelman SM, Chiodo LA (1983) Amphetamine as a stressor. In: Creese I (ed), Stimulants: neurochemical, behavioral and clinical perspectives Raven Press, New York, pp 269–299
Antelman SM, Eichler AJ (1979) Persistent effects of stress on dopamine-related behaviors; clinical implications. In: Usdin E Kopin IJ, Barchas J (eds) Catecholamines: basic and clinical frontiers. Pergamon Press, New York, pp 1759–1761
Antelman SM, Eichler AJ, Black CA, Kocan D (1980) Interchangeability of stress and amphetamine in sensitization. Science 207:329–331
Antelman SM, Kocan D, Edwards DJ, Knopf S, Perel JM, Stiller R (1986) Behavioral effects of a single neuroleptic treatment grow with the passage of time. Brain Res 385:58–67
Antelman SM, Kocan D, Edwards DJ, Knopf S (1987) A single injection of diazepam induces long-lasting sensitization. Psychopharmacol Bull 23:430–434
Antelman SM, Knopf S, Kocan D, Edwards SJ, Ritchie JC, Nemeroff CB (1988) One stressful event blocks multiple actions of diazepam for up to at least a month. Brain Res 445:380–385
Berg I, Marks I, McGuire R, Lipsedge M (1974) School phobia and agoraphobia. Psychol Med 4:428–434
Breier A, Charney DS Heninger GR (1986) Agoraphobia with panic attacks: development, diagnostic stability and course of illness. Arch Gen Psychiatry 43:1029–1036
Charney DS, Heninger GR (1986) Abnormal regulation of noradrenergic function in panic disorders. Arch Gen Psychiatry 43:1042–1058
Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751–763
Creese I, Kuczenski R, Segal, D (1982) Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock. Pharmacol Biochem Behav 17:375–376
Edwards DJ, Sorisio DA, Sedlock ML (1988) On the mechanism of imipramine's influence in lowering p-hydroxyphenylglycol concentrations in the brain: the role of tyrosine. Biochem Pharmacol 37:2059–2067
Finlay-Jones R, Brown GW (1981) Types of stressful life events and the onset of anxiety and depressive disorders. Psychol Med 11:803–815
Gittelman R, Klein, D (1985) Childhood separation anxiety and adult agoraphobia. In: Tuma HA, Maser JD (eds) Anxiety and the anxiety disorders. Erlbaum, Hillsdale, pp 389–402
Heffner TG, Hartman JA, Seiden LS (1980) A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13:453–456
Hennessy MB, Levine S (1977) Effects of various habituation procedures on pituitary-adrenal responsiveness in the mouse. Physiol Behav 18:799–802
Katon W (1986) Panic disorder: epidemiology, diagnosis and treatment in primary care. J Clin Psychiatry 47:21–27
Klein DF (1964) The delineation of two drug-responsive anxiety syndromes. Psychopharmacology 5:397–408
Lal H, Emmett-Oglesby MW (1983) Behavioral analogues of anxiety. Neuropharmacology 22:1423–1441
Murphy BE (1967) Some studies on the protein binding of steroids and their application to the routine micro and ultra-micro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol 12:973–990
Nutt DJ (1986) Increased central alpha-2-adrenoceptor sensitivity in panic disorder. Psychopharmacology 90:268–269
Post RM, Uhde TW, Joffe RT, Brier L (1986) Psychiatric manifestations and implications of seizures disorders. In: Extein I, Gold MS (eds) Medical mimics of psychiatric disorders. American Psychiatric Press, Washington, pp 35–91
Raskin M, Peeke HVS, Dickman W, Pinsker H (1982) Panic and generalized anxiety disorders: developmental antecedents and precipitants. Arch Gen Psychiatry 329:687–689
Redmond DE Jr, Huang YH (1979) Current concepts II. New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci 25:2149–2162
Reinhard JF Jr, Roth RH (1982) Noradrenergic modulation of serotonin synthesis and metabolism. I. Inhibition by clonidine in vivo. J Pharmacol Exp Ther 221:541–546
Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157–198
Robinson TE, Angus AL, Becker JB (1985) Sensitization to stress: the enduring effects of prior stress on amphetamine-induced rotational behavior. Life Sci 37:1039–1042
Rodin EA (1958) Metrazol tolerance in a “normal” and volunteer population. Electroencephalogr Clin Neurophysiol 10:433–446
Roth M (1959) The phobic anxiety-depersonalization syndrome. Proc R Soc Med 52:587–595
Sedlock ML, Edwards DJ (1985) Opposite effects of chronic imipramine treatment on brain and urine MHPG levels in the rat. Biol Psychiatry 20:858–865
Shipley JE, Rowland N, Antelman SM, Buggy J, Edwards DJ, Shapiro AP (1981) Increased amphetamine stereotypy and longer haloperidol catalepsy in spontaneously hypertensive rats. Life Sci 28:745–753
Uhde TW, Roy-Byrne PP, Vittone BJ, Boulenger JP, Post RM (1985) Phenomenology and neurobiology of panic disorder. In: Tuma HA, Maser JD (eds) Anxiety and the anxiety disorders. Erlbaum, Hillsdale, pp 557–576
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Antelman, S.M., Knopf, S., Kocan, D. et al. Persistent sensitization of clonidine-induced hypokinesia following one exposure to a stressor: possible relevance to panic disorder and its treatment. Psychopharmacology 98, 97–101 (1989). https://doi.org/10.1007/BF00442013
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442013